Drugs & TargetsFree Imbruvica + rituximab becomes first non-chemo combination for Waldenström’s macroglobulinemia August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves lenvatinib for unresectable hepatocellular carcinoma August 31, 2018Vol.44 No.32
Drugs & TargetsFree Lenvima gets European approval for advanced, unresectable hepatocellular carcinoma August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves pembrolizumab + chemo for first-line metastatic non-squamous NSCLC August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA updates prescribing information for Keytruda, Tecentriq August 31, 2018Vol.44 No.32
Drugs & TargetsFree Nivolumab gets accelerated approval for third-line metastatic small cell lung cancer August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves Kyowa Kirin’s Poteligeo for mycosis fungoides and Sézary Syndrome August 31, 2018Vol.44 No.32
Clinical RoundupFree NCCN publishes first U.S. guidelines for rare cancers associated with pregnancy August 31, 2018Vol.44 No.32
Clinical RoundupFree Collection of brain cancer data accessible to global researchers August 31, 2018Vol.44 No.32
Clinical RoundupFree Comprehensive CAR T-cell therapy pediatric guidelines developed August 31, 2018Vol.44 No.32
